These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1535 related items for PubMed ID: 8674031

  • 21. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
    Wang QM, Luo X, Kheir A, Coffman FD, Studzinski GP.
    Oncogene; 1998 May 28; 16(21):2729-37. PubMed ID: 9652739
    [Abstract] [Full Text] [Related]

  • 22. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
    Li W, Fan J, Bertino JR.
    Cancer Res; 2001 Mar 15; 61(6):2579-82. PubMed ID: 11289134
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R, Laín S, Ball KL, Lane DP.
    Oncogene; 1998 Feb 05; 16(5):587-96. PubMed ID: 9482104
    [Abstract] [Full Text] [Related]

  • 24. Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors.
    Kwon TK, Buchholz MA, Chrest FJ, Nordin AA.
    Cell Growth Differ; 1996 Oct 05; 7(10):1305-13. PubMed ID: 8891334
    [Abstract] [Full Text] [Related]

  • 25. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ, Chang CY, Lin JK.
    Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329
    [Abstract] [Full Text] [Related]

  • 26. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
    Yin F, Wakino S, Liu Z, Kim S, Hsueh WA, Collins AR, Van Herle AJ, Law RE.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):916-22. PubMed ID: 11527386
    [Abstract] [Full Text] [Related]

  • 27. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 28. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V, Senderowicz AM, Pinto D, Igishi T, Raffeld M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS.
    J Clin Invest; 1998 Nov 01; 102(9):1674-81. PubMed ID: 9802881
    [Abstract] [Full Text] [Related]

  • 29. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.
    Cell Growth Differ; 1996 Feb 01; 7(2):135-46. PubMed ID: 8822197
    [Abstract] [Full Text] [Related]

  • 30. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S, Debernardi S, Taya Y, Fontanella E, Airoldi R, Delia D.
    Oncogene; 2000 Aug 17; 19(35):4035-41. PubMed ID: 10962560
    [Abstract] [Full Text] [Related]

  • 31. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
    Kim WH, Kang KH, Kim MY, Choi KH.
    Biochem Cell Biol; 2000 Aug 17; 78(2):127-35. PubMed ID: 10874474
    [Abstract] [Full Text] [Related]

  • 32. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 17; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 33. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM, Dickson RB.
    Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151
    [Abstract] [Full Text] [Related]

  • 34. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
    Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K.
    Cancer Res; 2003 Jan 01; 63(1):93-9. PubMed ID: 12517783
    [Abstract] [Full Text] [Related]

  • 35. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 36. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T, Yang JL, Price JO, Arteaga CL.
    Exp Cell Res; 1998 Dec 15; 245(2):350-9. PubMed ID: 9851876
    [Abstract] [Full Text] [Related]

  • 37. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL.
    Cancer Res; 2001 Sep 01; 61(17):6583-91. PubMed ID: 11522658
    [Abstract] [Full Text] [Related]

  • 38. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
    Ponzio G, Loubat A, Rochet N, Turchi L, Rezzonico R, Farahi Far D, Dulic V, Rossi B.
    Oncogene; 1998 Sep 03; 17(9):1159-66. PubMed ID: 9764826
    [Abstract] [Full Text] [Related]

  • 39. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS, Lee WJ, Lee SW, Chae HW, Kim DH, Oh Y.
    Horm Metab Res; 2010 Mar 03; 42(3):165-72. PubMed ID: 19960406
    [Abstract] [Full Text] [Related]

  • 40. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF, Faure R, Piedboeuf B, Mirault ME.
    Exp Cell Res; 2000 May 01; 256(2):347-57. PubMed ID: 10772807
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 77.